Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quick International Courier is a global provider of time-critical transportation and logistics services, with particular strength in pharma, biotech, healthcare, and life sciences shipments. The company has specialized capabilities for temperature-controlled and chain-of-custody-sensitive deliveries, including clinical trial materials, investigational drugs, biological samples, organs, tissue, blood products, and cell and gene therapy logistics. Historically, Quick operated through product brands including QuickSTAT, Quick Healthcare, Quick Logistics, and Sterling Aviation, serving both healthcare and non-healthcare sectors such as aerospace and high-tech. In 2018, Quick International Courier was acquired by Kuehne + Nagel, and its brands continued operating within the broader group. For a biotech analyst, this is best understood not as a drug developer but as a specialized commercial logistics and supply-chain services company supporting mission-critical healthcare transport.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quick International Courier.